Hologic (NSDQ:HOLX) posted fiscal first-quarter results today that beat the consensus forecast on Wall Street and increased its outlook for the rest of the year.
“We expect upside from COVID-19 testing, plus organic growth in our base Diagnostics and Surgical businesses, to offset headwinds from supply chain challenges in our Breast Health business,” CFO Karleen Oberton said in a news release.